The 'worm' holds the key to treating epilepsy—new possibilities for rapid drug discovery

September 26, 2016
Monica Risley, co-lead author and a Ph.D. student in FAU’s Integrative Biology and Neuroscience program, as well as a student in the new International Max Planck Research School in Brain and Behavior. Credit: Florida Atlantic University

Current methods to control epilepsy, which affects 1 in 26 Americans, are not only inefficient but haven't improved in more than 150 years when the first anticonvulsant drug was developed. Treatment options include invasive surgeries and a combination of antiepileptic drugs that surprisingly don't work in more than 30 percent of patients. Noninvasive treatments are limited for easing symptoms partially due to the complexity of the disorder and lack of knowledge of specific molecular malfunctions. In recent years, fewer and fewer drugs have been introduced into the market most likely due to exhausted screening techniques and less efficient methods for predicting drug effectiveness.

Researchers from Florida Atlantic University, in collaboration with The Scripps Research Institute, have opened up the possibilities for rapid drug screens to treat seizures in the near future by developing the smallest whole-animal electroconvulsive seizure model using a microscopic nematode worm. Electroshock is one of the most common experimental models of acute and chronic seizure in mammals to study epilepsy. The researchers have been able to demonstrate, that just like rodents and even fruit flies, the tiny 1 millimeter C.elegans worm also can undergo an electroconvulsive seizure.

The study, "Modulating Behavior in C.elegans Using Electroshock and Antiepileptic Drugs," just published in PLOS One, has led the researchers to build on the current animal models for inducing seizures via electroconvulsion in the genetically modifiable C.elegans that only has 302 brain cells called neurons. C.elegans has been used for decades as a model animal to study the genetic and molecular underpinnings of neurological disorders through a number of techniques including bio imaging, electrophysiology and behavior.

For the study, researchers treated the worms with several antiepileptic drugs approved for human use, which improved recovery from electroshock seizures worsened by genetic or pharmacological pro-convulsants.

"We were very excited to discover that when we used a typical genetic mutation that was more susceptible to electroconvulsive seizures, we were able to actually rescue these worms by treating them with FDA approved human antiepileptic drugs beforehand," said Monica Risley, co-lead author and a Ph.D. student in FAU's Integrative Biology and Neuroscience program, as well as a student in the new International Max Planck Research School in Brain and Behavior.

Because this new method is rapid, inexpensive and has shown relevance with existing antiepileptic drugs, the C.elegans electroshock assay developed at FAU has the potential to become an efficient screening tool for human seizure therapeutics.

"The fact that we can induce a short seizure, of approximately 1 to 3 minutes long, with the exact timing of an electrical pulse, and that these worms react well to , makes this new assay a perfect model for high-speed drug screens in multi-welled plate readers," said Ken Dawson-Scully, Ph.D., corresponding author and associate professor in the Department of Biological Sciences and associate director of the FAU Brain Institute.

Dawson-Scully notes that the ability to use C.elegans in high speed robotic drug testing facilities like those at Scripps Florida, will enable testing of hundreds of thousands of compounds, even in combinations, using this automated process. "The cost to run high throughput testing for antiepileptic drug candidates would cost a fraction in time and money compared to the experiments available today," said Dawson-Scully.

Explore further: Some psychotic disorders may be induced by drugs designed to combat effects of epilepsy

More information: Monica G. Risley et al. Modulating Behavior in C. elegans Using Electroshock and Antiepileptic Drugs, PLOS ONE (2016). DOI: 10.1371/journal.pone.0163786

Related Stories

Some psychotic disorders may be induced by drugs designed to combat effects of epilepsy

August 9, 2016
Today Brain publishes a new study indicating that antiepileptic drugs designed to reduce seizures, may also induce psychotic disorders in some patients.

Recommendations address how to manage seizures in infants

June 1, 2015
New recommendations offer insights on strategies for treating infants with seizures. In an Epilepsia report, child neurologists who are members of the International League Against Epilepsy note that intervening at the time ...

Scientists fish for new epilepsy model and reel in potential drug

September 3, 2013
According to new research on epilepsy, zebrafish have certainly earned their stripes. Results of a study in Nature Communications suggest that zebrafish carrying a specific mutation may help researchers discover treatments ...

Polypharamocological drugs in the treatment of epilepsy: The comprehensive review of marketed and new emerging molecules

July 13, 2016
The researchers in the laboratory of Dr. Manisha Tiwari have recently reviewed "Polypharamocological Drugs in the Treatment of Epilepsy: The Comprehensive Review of Marketed and New Emerging Molecules".

Folic acid during pregnancy could help to prevent autism caused by antiepileptic drugs

June 1, 2016
If pregnant women take antiepileptic drugs, the child can develop autistic traits. The administration of folic acid preparations appears to be a suitable means of preventing this serious side-effect. This finding is suggested ...

Treatments available for drug-resistant epilepsy

August 22, 2016
One in 26 people will develop epilepsy – a chronic disease characterized by unpredictable seizures—in their lifetime.

Recommended for you

Mechanism explains how seizures may lead to memory loss

October 16, 2017
Although it's been clear that seizures are linked to memory loss and other cognitive deficits in patients with Alzheimer's disease, how this happens has been puzzling. In a study published in the journal Nature Medicine, ...

Study shows people find well-being more so from special places than from mementoes

October 16, 2017
(Medical Xpress)—A team of researchers at the University of Surrey has found that people experience a feeling of well-being when thinking about or visiting a place that holds special meaning to them. They also found that ...

New study describes how dopamine tells you it isn't worth the wait

October 16, 2017
How do we know if it was worth the wait in line to get a meal at the new restaurant in town? To do this our brain must be able to signal how good the meal tastes and associate this feeling with the restaurant. This is done ...

Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer's disease

October 13, 2017
Microglia, immune cells that act as the central nervous system's damage sensors, have recently been implicated in Alzheimer's disease.

Restless legs syndrome study identifies 13 new genetic risk variants

October 13, 2017
A new study into the genetics underlying restless legs syndrome has identified 13 previously-unknown genetic risk variants, while helping inform potential new treatment options for the condition.

Blueberries may improve attention in children following double-blind trial

October 13, 2017
Primary school children could show better attention by consuming flavonoid-rich blueberries, following a study conducted by the University of Reading.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.